PARIS: Sanofi-Synthelabo SA launched a hostile 48 billion euros (US$61bil) bid for larger rival Aventis SA yesterday in a move to create one of the world’s top three pharmaceutical companies.
France’s second largest drugmaker is offering five of its shares for six Aventis shares plus 69 euros in cash. It said 81% of the offer was in shares and 19% cash.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!